نتایج جستجو برای: biomarker validation

تعداد نتایج: 227799  

2010
Alok Mishra Mukesh Verma

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. In cancer, a biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker might be either a molecule secreted by a tumor or it can be a specific...

2011
Brian Dean

The search for clinically useful biomarkers has been one of the holy grails of schizophrenia research. This paper will outline the evolving notion of biomarkers and then outline outcomes from a variety of biomarkers discovery strategies. In particular, the impact of high-throughput screening technologies on biomarker discovery will be highlighted and how new or improved technologies may allow t...

Journal: :Clinical trials 2012
Tze Leung Lai Philip W Lavori Mei-Chiung I Shih Branimir I Sikic

BACKGROUND Advances in molecular therapeutics in the past decade have opened up new possibilities for treating cancer patients with personalized therapies, using biomarkers to determine which treatments are most likely to benefit them, but there are difficulties and unresolved issues in the development and validation of biomarker-based personalized therapies. We develop a new clinical trial des...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Theresa L Whiteside Soldano Ferrone

The stromal immunoglobulin kappa chain (IGKC) has been validated as an immunologic biomarker of prognosis and response to therapy in human breast cancer and other cancers. This validation emphasizes the key role of humoral immunity in control of cancer progression and has major implications for determining prognosis of patients with cancer.

Journal: :گوارش 0
elnaz naderimanesh soudabeh jahanbakhshkadehkahriz ashraf mohammadkhani

saliva is multifunctional; it is a lubricant for speech, aide for food digestion, and protective against microorganisms. it is voluntarily accessible, composed of proteins and electrolytes, and is ideal for the early detection of a wide range of diseases. because of a complex protein mixture, saliva proteomics has the potential to be a novel approach in the search for protein biomarkers. most s...

Journal: :Molecular oncology 2012
N Lynn Henry Daniel F Hayes

Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinica...

Journal: :Bioanalysis 2017
Philip Timmerman Marianne Scheel Fjording John Allinson Cecilia Arfvidsson Begoña Barroso Ulf Diczfalusy Adrian Freeman Elizabeth Hickford Hamza Kandousi Sidath Katugampola Ulrich Kunz Robert Nelson John Smeraglia

European Bioanalysis Forum Focus Workshop, Lisbon, Portugal, 9-10 June 2016 At the recent European Bioanalysis Forum's Focus Workshop 'Bringing Assay Validation and Analysis of Biomarkers into Practice', the discussion on best practice for biomarker assay validation continued. Both the presentations and the adjacent panel discussions yielded valuable food for thought for the broader bioanalytic...

Journal: :The Journal of clinical psychiatry 2015
John A Bilello Linda M Thurmond Katie M Smith Bo Pi Robert Rubin Suzin M Wright Floyd Taub Michael E Henry Richard C Shelton George I Papakostas

BACKGROUND Previously, a biomarker panel was developed for use as an aid to major depressive disorder (MDD) diagnosis; it consisted of 9 biomarkers associated with the neurotrophic, metabolic, inflammatory, and hypothalamic-pituitary-adrenal axis pathways. This panel and associated algorithm produced good clinical sensitivity and specificity (92% and 81%, respectively) in differentiating MDD pa...

2010
Philipp Spitzer Hans Wolfgang Klafki Kaj Blennow Luc Buée Hermann Esselmann Sanna-Kaisa Herruka Connie Jimenez Peter Klivenyi Piotr Lewczuk Juan Manuel Maler Katrin Markus Helmut E. Meyer Chris Morris Thorsten Müller Markus Otto Lucilla Parnetti Hilkka Soininen Susanna Schraen Charlotte Teunissen Laszlo Vecsei Henrik Zetterberg Jens Wiltfang

"clinical NEUroPROteomics of neurodegenerative diseases" (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable ...

Journal: :CoRR 2016
Alex Zwanenburg Stefan Leger Martin Vallières Steffen Löck

on behalf of the image biomarker standardisation initiative The image biomarker standardisation initiative (IBSI) is an independent international collaboration which works towards standardisation of image biomarkers. Reproducibility and validation of studies in quantitative image analysis/ radiomics is a major challenge for the field (Gillies et al., 2015; Hatt et al., 2016; Yip and Aerts, 2016...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید